METHODS	After an overnight fast and a basal period of 1 h , 0.6 nmol/kg of either 125I-labeled human soluble insulin ( Actrapid HM U-100 ) or 125I-labeled analogue was injected subcutaneously on 4 separate days 1 wk apart .\